VISCGO LIMITEDActive

Company number 09744207Private limited companyIncorporated 2015

Key figures

−£186,153-23.2%
Net assets 2023/24
-200 k-100 k0100 k2019/202020/212021/222022/232023/24

VISCGO LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Profit for the year—-120,086-137,583-161,307-123,428
Cash at bank and in hand29,950186,05968,0391,01529,886
Total assets72,833300,026237,546177,952187,363
Total liabilities107,332202,261227,364329,077373,516
Net assets / total equity-34,49997,76510,182-151,125-186,153
Average number of employees34633

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: VISCGO LIMITED

Company

VISCGO LIMITED is a private limited company registered with Companies House under company number 09744207. It was incorporated on 21 Aug 2015. Its status is active. The registered office is in Manchester (M25). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2023/24 (period ending 31 Aug 2024); the company files small company accounts (filleted). Loss for the year was £123,428. Net assets were −£186,153, down 23.2% on the previous year. Cash at bank and in hand was £29,886. Total assets were £187,363 and total liabilities £373,516. The company had an average of 3 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 26 Nov 2026. The next confirmation statement is due by 19 Feb 2027.